The limited efficacy was hypothesized to be primarily due to the decreased cytotoxic potency that the CAR-NK-92 cells had after the irradiation step, as well as due to the insufficient phenotypic evaluation of the CD33+/high AML populations. Here, CD33 is linked to acute myeloid leukemia.